Literature DB >> 20196919

Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats.

Junran Cao1, Jennifer B Dwyer, Jamie E Mangold, Ju Wang, Jinxue Wei, Frances M Leslie, Ming D Li.   

Abstract

Maternal smoking during pregnancy (MS) has long-lasting neurobehavioural effects on the offspring. Many MS-associated psychiatric disorders begin or change symptomatology during adolescence, a period of continuous development of the central nervous system. However, the underlying molecular mechanisms are largely unknown. Given that cell adhesion molecules (CAMs) modulate various neurotransmitter systems and are associated with many psychiatric disorders, we hypothesize that CAMs are altered by prenatal treatment of nicotine, the major psychoactive component in tobacco, in adolescent brains. Pregnant Sprague-Dawley rats were treated with nicotine (3 mg/kg.d) or saline via osmotic mini-pumps from gestational days 4 to 18. Female offspring at postnatal day 35 were sacrificed, and several limbic brain regions (the caudate putamen, nucleus accumbens, prefrontal cortex, and amygdala) were dissected for evaluation of gene expression using microarray and quantitative RT-PCR techniques. Various CAMs including neurexin, immunoglobulin, cadherin, and adhesion-GPCR superfamilies, and their intracellular signalling pathways were modified by gestational nicotine treatment (GN). Among the CAM-related pathways, GN has stronger effects on cytoskeleton reorganization pathways than on gene transcription pathways. These effects were highly region dependent, with the caudate putamen showing the greatest vulnerability. Given the important roles of CAMs in neuronal development and synaptic plasticity, our findings suggest that alteration of CAMs contributes to the neurobehavioural deficits associated with MS. Further, our study underscores that low doses of nicotine produce substantial and long-lasting changes in the brain, implying that nicotine replacement therapy during pregnancy may carry many of the same risks to the offspring as MS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20196919      PMCID: PMC5575906          DOI: 10.1017/S1461145710000179

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  86 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

2.  Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence.

Authors:  Miles Gregory Cunningham; Sujoy Bhattacharyya; Francine Mary Benes
Journal:  J Comp Neurol       Date:  2002-11-11       Impact factor: 3.215

Review 3.  Synaptic adhesion molecules.

Authors:  Masahito Yamagata; Joshua R Sanes; Joshua A Weiner
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

4.  Increased nicotine self-administration following prenatal exposure in female rats.

Authors:  Edward D Levin; Susan Lawrence; Ann Petro; Kofi Horton; Frederic J Seidler; Theodore A Slotkin
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

Review 5.  Catecholamine regulation of the prefrontal cortex.

Authors:  A F Arnsten
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

6.  Combined exposure to nicotine and ethanol throughout full gestation results in enhanced acquisition of nicotine self-administration in young adult rat offspring.

Authors:  Shannon G Matta; Andrea J Elberger
Journal:  Psychopharmacology (Berl)       Date:  2007-04-03       Impact factor: 4.530

7.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 8.  Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.

Authors:  Karen Markussen Linnet; Søren Dalsgaard; Carsten Obel; Kirsten Wisborg; Tine Brink Henriksen; Alina Rodriguez; Arto Kotimaa; Irma Moilanen; Per Hove Thomsen; Jørn Olsen; Marjo-Riitta Jarvelin
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

9.  Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms.

Authors:  Akitoyo Hishimoto; Qing-Rong Liu; Tomas Drgon; Olga Pletnikova; Donna Walther; Xu-Guang Zhu; Juan C Troncoso; George R Uhl
Journal:  Hum Mol Genet       Date:  2007-09-04       Impact factor: 6.150

Review 10.  Cigarette smoking during pregnancy.

Authors:  Alison K Shea; Meir Steiner
Journal:  Nicotine Tob Res       Date:  2008-02       Impact factor: 4.244

View more
  20 in total

1.  Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages.

Authors:  Wen-Yan Cui; Shufang Zhao; Renata Polanowska-Grabowska; Ju Wang; Jinxue Wei; Bhagirathi Dash; Sulie L Chang; Jeffrey J Saucerman; Jun Gu; Ming D Li
Journal:  Mol Pharmacol       Date:  2012-10-01       Impact factor: 4.436

2.  Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells.

Authors:  Wen-Yan Cui; Ju Wang; Jinxue Wei; Junran Cao; Sulie L Chang; Jun Gu; Ming D Li
Journal:  Amino Acids       Date:  2011-12-21       Impact factor: 3.520

Review 3.  Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment.

Authors:  Claudia V Morris; Jennifer A DiNieri; Henrietta Szutorisz; Yasmin L Hurd
Journal:  Eur J Neurosci       Date:  2011-11       Impact factor: 3.386

4.  Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex.

Authors:  Yuki Aoyama; Kazuya Toriumi; Akihiro Mouri; Tomoya Hattori; Eriko Ueda; Akane Shimato; Nami Sakakibara; Yuka Soh; Takayoshi Mamiya; Taku Nagai; Hyoung-Chun Kim; Masayuki Hiramatsu; Toshitaka Nabeshima; Kiyofumi Yamada
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

5.  Central myelin gene expression during postnatal development in rats exposed to nicotine gestationally.

Authors:  Junran Cao; Jennifer B Dwyer; Nicole M Gautier; Frances M Leslie; Ming D Li
Journal:  Neurosci Lett       Date:  2013-08-17       Impact factor: 3.046

6.  Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.

Authors:  Zhongli Yang; Tanseli Nesil; Kaitlyn P Connaghan; Ming D Li; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-04       Impact factor: 4.147

7.  HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats.

Authors:  Zhongli Yang; Tanseli Nesil; Taylor Wingo; Sulie L Chang; Ming D Li
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

8.  Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways.

Authors:  Ju Wang; Wenyan Cui; Jinxue Wei; Dongxiao Sun; Ramana Gutala; Jun Gu; Ming D Li
Journal:  Front Psychiatry       Date:  2011-03-08       Impact factor: 4.157

9.  Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat.

Authors:  Ming D Li; Junran Cao; Shaolin Wang; Ju Wang; Sraboni Sarkar; Michael Vigorito; Jennie Z Ma; Sulie L Chang
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

10.  Gestational nicotine exposure modifies myelin gene expression in the brains of adolescent rats with sex differences.

Authors:  J Cao; J Wang; J B Dwyer; N M Gautier; S Wang; F M Leslie; M D Li
Journal:  Transl Psychiatry       Date:  2013-04-16       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.